NCT02574520 - Trial of Extended Release Bupivacaine for Pain Relief After Surgery | Biotech Hunter

Enrollment

399

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

June 30, 2017

Study Completion Date

August 31, 2017

Conditions

Post Operative Pain

Interventions

DRUG

SABER-Bupivacaine (Part 1)

5 ml once at end of surgery

DRUG

SABER-Bupivacaine (Part 2)

5 ml once at end of surgery

DRUG

Saline Placebo

5 ml once at end of surgery

DRUG

Bupivacaine HCl

0.5%, 15 ml, once at end of surgery

Trial Locations (21)

11794

Durect Study Site 05, Stony Brook

19107

Durect Study Site 14, Philadelphia

27710

Durect Study Site 13, Durham

32503

Durect Study Site 22, Pensacola

35360

Durect Study Site 04, Florence

35660

Durect Study Site 03, Sheffield

39202

Durect Study Site 17, Jackson

44106

Durect Study Site 09, Cleveland

44111

Durect Study Site 11, Cleveland

44195

Durect Study Site 07, Cleveland

46202

Durect Study Site 12, Indianapolis

48073

Durect Study Site 21, Royal Oak

75093

Durect Study Site 23, Plano

77004

Durect Study Site 08, Houston

77043

DURECT Study Site 01, Houston

89104

Durect Study Site 16, Las Vegas

89109

Durect Study Site 20, Las Vegas

91007

DURECT Study Site 24, Arcadia

92335

Durect Study Site 15, Fontana

92653

Durect Study Site 02, Laguna Hills

Durect Study Site 18, Laguna Hills